Imugene Limited (IMU.AX)
AUD 0.03
(7.69%)
AUD 0.03
(7.69%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -91.56 Million AUD | 40.0% |
| 2023 | -152.59 Million AUD | -53.81% |
| 2022 | -99.21 Million AUD | -239.59% |
| 2021 | -29.21 Million AUD | 2.73% |
| 2020 | -30.03 Million AUD | -58.72% |
| 2019 | -18.92 Million AUD | -141.94% |
| 2018 | -7.82 Million AUD | -62.48% |
| 2017 | -4.81 Million AUD | -204.2% |
| 2016 | -1.58 Million AUD | 19.13% |
| 2015 | -1.95 Million AUD | -60.03% |
| 2014 | -1.22 Million AUD | -116.2% |
| 2013 | -565.62 Thousand AUD | 44.37% |
| 2012 | -1.01 Million AUD | 46.65% |
| 2011 | -1.9 Million AUD | -140.33% |
| 2010 | -793.06 Thousand AUD | 68.12% |
| 2009 | -2.48 Million AUD | -53.57% |
| 2008 | -1.61 Million AUD | -47.35% |
| 2007 | -1.09 Million AUD | 59.25% |
| 2006 | -2.69 Million AUD | 37.94% |
| 2005 | -4.34 Million AUD | -351.46% |
| 2004 | -962.74 Thousand AUD | 63.22% |
| 2003 | -2.61 Million AUD | -234.33% |
| 2002 | -783 Thousand AUD | -165.97% |
| 2001 | 1.18 Million AUD | 1114.46% |
| 2000 | -117 Thousand AUD | 93.73% |
| 1999 | -1.86 Million AUD | -54.3% |
| 1998 | -1.21 Million AUD | 17.74% |
| 1997 | -1.47 Million AUD | -206.44% |
| 1996 | 1.38 Million AUD | 269.52% |
| 1995 | 374 Thousand AUD | 106.77% |
| 1994 | -5.52 Million AUD | -12946.51% |
| 1993 | 43 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -135.21 Million AUD | 0.0% |
| 2024 FY | -91.56 Million AUD | 40.0% |
| 2024 Q4 | -91.56 Million AUD | 0.0% |
| 2023 Q2 | -161.48 Million AUD | 0.0% |
| 2023 Q4 | -152.59 Million AUD | 0.0% |
| 2023 FY | -152.59 Million AUD | -53.81% |
| 2022 FY | -99.21 Million AUD | -239.59% |
| 2022 Q2 | -118.4 Million AUD | 0.0% |
| 2022 Q4 | -99.21 Million AUD | 0.0% |
| 2021 FY | -29.21 Million AUD | 2.73% |
| 2021 Q2 | -32.83 Million AUD | 0.0% |
| 2021 Q4 | -29.21 Million AUD | 0.0% |
| 2020 FY | -30.03 Million AUD | -58.72% |
| 2020 Q4 | -30.03 Million AUD | 0.0% |
| 2020 Q2 | -36.73 Million AUD | 0.0% |
| 2019 FY | -18.92 Million AUD | -141.94% |
| 2019 Q4 | -18.92 Million AUD | 0.0% |
| 2019 Q2 | -23.95 Million AUD | 0.0% |
| 2018 Q2 | -11.92 Million AUD | 0.0% |
| 2018 FY | -7.82 Million AUD | -62.48% |
| 2018 Q4 | -7.82 Million AUD | 0.0% |
| 2017 FY | -4.81 Million AUD | -204.2% |
| 2017 Q4 | -4.81 Million AUD | 0.0% |
| 2017 Q2 | -3.82 Million AUD | 0.0% |
| 2016 Q4 | -1.58 Million AUD | 0.0% |
| 2016 FY | -1.58 Million AUD | 19.13% |
| 2016 Q2 | -3.72 Million AUD | 0.0% |
| 2015 Q2 | -2.99 Million AUD | 0.0% |
| 2015 FY | -1.95 Million AUD | -60.03% |
| 2015 Q4 | -1.95 Million AUD | 0.0% |
| 2014 Q2 | -2.46 Million AUD | 0.0% |
| 2014 FY | -1.22 Million AUD | -116.2% |
| 2014 Q4 | -1.22 Million AUD | 0.0% |
| 2013 Q2 | -747.47 Thousand AUD | 0.0% |
| 2013 Q4 | -565.62 Thousand AUD | 0.0% |
| 2013 FY | -565.62 Thousand AUD | 44.37% |
| 2013 Q1 | -747.47 Thousand AUD | 26.48% |
| 2013 Q3 | -565.62 Thousand AUD | 24.33% |
| 2012 Q4 | -1.01 Million AUD | 0.0% |
| 2012 FY | -1.01 Million AUD | 46.65% |
| 2011 Q4 | -1.9 Million AUD | 0.0% |
| 2011 FY | -1.9 Million AUD | -140.33% |
| 2010 FY | -793.06 Thousand AUD | 68.12% |
| 2010 Q4 | -793.06 Thousand AUD | 0.0% |
| 2009 FY | -2.48 Million AUD | -53.57% |
| 2009 Q4 | -2.48 Million AUD | 0.0% |
| 2008 FY | -1.61 Million AUD | -47.35% |
| 2008 Q4 | -1.61 Million AUD | 0.0% |
| 2007 FY | -1.09 Million AUD | 59.25% |
| 2007 Q4 | -1.09 Million AUD | 0.0% |
| 2006 FY | -2.69 Million AUD | 37.94% |
| 2006 Q4 | -2.69 Million AUD | 0.0% |
| 2005 FY | -4.34 Million AUD | -351.46% |
| 2005 Q4 | -4.34 Million AUD | 0.0% |
| 2004 Q4 | -962.74 Thousand AUD | 0.0% |
| 2004 FY | -962.74 Thousand AUD | 63.22% |
| 2003 FY | -2.61 Million AUD | -234.33% |
| 2003 Q4 | -2.61 Million AUD | 0.0% |
| 2002 Q4 | -782.96 Thousand AUD | 0.0% |
| 2002 FY | -783 Thousand AUD | -165.97% |
| 2001 Q4 | 1.18 Million AUD | 0.0% |
| 2001 FY | 1.18 Million AUD | 1114.46% |
| 2000 Q4 | -116.71 Thousand AUD | 0.0% |
| 2000 FY | -117 Thousand AUD | 93.73% |
| 1999 Q4 | -1.86 Million AUD | 0.0% |
| 1999 FY | -1.86 Million AUD | -54.3% |
| 1998 FY | -1.21 Million AUD | 17.74% |
| 1997 Q4 | -1.47 Million AUD | 0.0% |
| 1997 FY | -1.47 Million AUD | -206.44% |
| 1996 FY | 1.38 Million AUD | 269.52% |
| 1995 FY | 374 Thousand AUD | 106.77% |
| 1994 FY | -5.52 Million AUD | -12946.51% |
| 1993 FY | 43 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AdAlta Limited | -845.17 Thousand AUD | -10733.357% |
| Acrux Limited | -1.45 Million AUD | -6179.877% |
| Race Oncology Limited | -17.18 Million AUD | -432.675% |
| Biome Australia Limited | -1.56 Million AUD | -5758.728% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | -15.449% |
| BTC Health Limited | -2.02 Million AUD | -4427.873% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -2899.036% |
| CSL Limited | 15.76 Billion AUD | 100.581% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 32.925% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 49.964% |
| EZZ Life Science Holdings Limited | -18.89 Million AUD | -384.48% |
| Hexima Limited | -2.22 Million AUD | -4012.84% |
| Immutep Limited | -122.18 Million AUD | 25.067% |
| Memphasys Limited | 4.13 Million AUD | 2314.084% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | -435.63% |
| Noxopharm Limited | -2.31 Million AUD | -3846.702% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -800.948% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | -392.923% |
| Starpharma Holdings Limited | -19.83 Million AUD | -361.681% |
| Tissue Repair Ltd | -16.44 Million AUD | -456.902% |
| Biotron Limited | -386.06 Thousand AUD | -23616.188% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -633.668% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -9222.875% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -12803.894% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 1906.88% |
| Patrys Limited | -2.24 Million AUD | -3986.321% |
| Orthocell Limited | -19.92 Million AUD | -359.532% |
| PYC Therapeutics Limited | -65.76 Million AUD | -39.231% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -1347.862% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -1375.495% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -620.133% |
| Nanollose Limited | -96.22 Thousand AUD | -95052.622% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -1419.661% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -1748.163% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -4920.896% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -7293.406% |
| Nyrada Inc. | -4.76 Million AUD | -1819.762% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 13.452% |
| Dimerix Limited | -21.99 Million AUD | -316.34% |
| PharmAust Limited | -9.71 Million AUD | -842.553% |
| AnteoTech Limited | -5 Million AUD | -1730.654% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | -420.778% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -2596.025% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -1618.078% |
| Actinogen Medical Limited | -9.13 Million AUD | -902.671% |
| Immuron Limited | -11.48 Million AUD | -697.301% |
| Argenica Therapeutics Limited | -15.91 Million AUD | -475.395% |